• Back to miR-142-5p

• TSANG, Felice Ho-Ching, et al. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. Frontiers of medicine, 2015, 9.3: 331-343.
• ZHANG, X., et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Annals of oncology, 2011, 22.10: 2257-2266.
• LANDGRAF, Pablo, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 2007, 129.7: 1401-1414.
• DANGER, Richard, et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PloS one, 2013, 8.4: e60702.
• ANGLICHEAU, Dany, et al. MicroRNA expression profiles predictive of human renal allograft status. Proceedings of the National Academy of Sciences, 2009, 106.13: 5330-5335.
• LIU, Lingqi, et al. MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3. American journal of translational research, 2017, 9.5: 2394.
• SHARMA, Salil, et al. Repression of miR‐142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO molecular medicine, 2012, 4.7: 617-632.
• BARSANTI, Cristina, et al. Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading. BioMed research international, 2015, 2015.
• VOELLENKLE, Christine, et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiological genomics, 2010, 42.3: 420-426.